Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 313

1.

Discrete Changes in Glucose Metabolism Define Aging.

Ravera S, Podestà M, Sabatini F, Dagnino M, Cilloni D, Fiorini S, Barla A, Frassoni F.

Sci Rep. 2019 Jul 17;9(1):10347. doi: 10.1038/s41598-019-46749-w.

2.

Loss of whole chromosome X predicts prognosis of neuroblastoma patients with numerical genomic profile.

Parodi S, Pistorio A, Erminio G, Ognibene M, Morini M, Garaventa A, Gigliotti AR, Haupt R, Frassoni F, Pezzolo A.

Pediatr Blood Cancer. 2019 May;66(5):e27635. doi: 10.1002/pbc.27635. Epub 2019 Jan 28.

PMID:
30688024
3.

Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide.

Horwitz ME, Wease S, Blackwell B, Valcarcel D, Frassoni F, Boelens JJ, Nierkens S, Jagasia M, Wagner JE, Kuball J, Koh LP, Majhail NS, Stiff PJ, Hanna R, Hwang WYK, Kurtzberg J, Cilloni D, Freedman LS, Montesinos P, Sanz G.

J Clin Oncol. 2019 Feb 10;37(5):367-374. doi: 10.1200/JCO.18.00053. Epub 2018 Dec 4.

4.

Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma.

Morandi F, Frassoni F, Ponzoni M, Brignole C.

J Immunol Res. 2018 Oct 30;2018:8097398. doi: 10.1155/2018/8097398. eCollection 2018. Review.

5.

CHL1 gene acts as a tumor suppressor in human neuroblastoma.

Ognibene M, Pagnan G, Marimpietri D, Cangelosi D, Cilli M, Benedetti MC, Boldrini R, Garaventa A, Frassoni F, Eva A, Varesio L, Pistoia V, Pezzolo A.

Oncotarget. 2018 May 25;9(40):25903-25921. doi: 10.18632/oncotarget.25403. eCollection 2018 May 25.

6.

Late Development of FcεRγneg Adaptive Natural Killer Cells Upon Human Cytomegalovirus Reactivation in Umbilical Cord Blood Transplantation Recipients.

Muccio L, Falco M, Bertaina A, Locatelli F, Frassoni F, Sivori S, Moretta L, Moretta A, Della Chiesa M.

Front Immunol. 2018 May 15;9:1050. doi: 10.3389/fimmu.2018.01050. eCollection 2018.

7.

Mesenchymal stem cells from preterm to term newborns undergo a significant switch from anaerobic glycolysis to the oxidative phosphorylation.

Ravera S, Podestà M, Sabatini F, Fresia C, Columbaro M, Bruno S, Fulcheri E, Ramenghi LA, Frassoni F.

Cell Mol Life Sci. 2018 Mar;75(5):889-903. doi: 10.1007/s00018-017-2665-z. Epub 2017 Oct 3.

PMID:
28975370
8.

EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells.

La Rocca F, Airoldi I, Di Carlo E, Marotta P, Falco G, Simeon V, Laurenzana I, Trino S, De Luca L, Todoerti K, Villani O, Lackmann M, D'Auria F, Frassoni F, Neri A, Del Vecchio L, Musto P, Cilloni D, Caivano A.

Cell Oncol (Dordr). 2017 Oct;40(5):483-496. doi: 10.1007/s13402-017-0338-4. Epub 2017 Jul 18.

9.

Clonal haematopoiesis is not prevalent in survivors of childhood cancer.

Collord G, Park N, Podestà M, Dagnino M, Cilloni D, Jones D, Varela I, Frassoni F, Vassiliou GS.

Br J Haematol. 2018 May;181(4):537-539. doi: 10.1111/bjh.14630. Epub 2017 Apr 3. No abstract available.

10.

A novel assay to detect calreticulin mutations in myeloproliferative neoplasms.

Rosso V, Petiti J, Bracco E, Pedrola R, Carnuccio F, Signorino E, Carturan S, Calabrese C, Bot-Sartor G, Ronconi M, Serra A, Saglio G, Frassoni F, Cilloni D.

Oncotarget. 2017 Jan 24;8(4):6399-6405. doi: 10.18632/oncotarget.14113.

11.

Variable but consistent pattern of Meningioma 1 gene (MN1) expression in different genetic subsets of acute myelogenous leukaemia and its potential use as a marker for minimal residual disease detection.

Carturan S, Petiti J, Rosso V, Calabrese C, Signorino E, Bot-Sartor G, Nicoli P, Gallo D, Bracco E, Morotti A, Panuzzo C, Gottardi E, Frassoni F, Saglio G, Cilloni D.

Oncotarget. 2016 Nov 8;7(45):74082-74096. doi: 10.18632/oncotarget.12269.

12.

The Wilms' tumor (WT1) gene expression correlates with the International Prognostic Scoring System (IPSS) score in patients with myelofibrosis and it is a marker of response to therapy.

Gallo D, Nicoli P, Calabrese C, Gaidano V, Petiti J, Rosso V, Signorino E, Carturan S, Bot-Sartor G, Volpe G, Frassoni F, Saglio G, Cilloni D.

Cancer Med. 2016 Jul;5(7):1650-3. doi: 10.1002/cam4.735. Epub 2016 May 11.

13.

Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study.

Gratwohl A, Iacobelli S, Bootsman N, van Biezen A, Baldomero H, Arcese W, Arnold R, Bron D, Cordonnier C, Ernst P, Ferrant A, Frassoni F, Gahrton G, Richard C, Kolb HJ, Link H, Niederwieser D, Ruutu T, Schattenberg A, Schmitz N, Torres-Gomez A, Zwaan F, Apperley J, Olavarria E, Kröger N; Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation EBMT.

Ann Hematol. 2016 May;95(6):967-72. doi: 10.1007/s00277-016-2638-6. Epub 2016 Mar 19.

PMID:
26994010
14.

MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantation.

De Luca L, Trino S, Laurenzana I, Simeon V, Calice G, Raimondo S, Podestà M, Santodirocco M, Di Mauro L, La Rocca F, Caivano A, Morano A, Frassoni F, Cilloni D, Del Vecchio L, Musto P.

Oncotarget. 2016 Feb 9;7(6):6676-92. doi: 10.18632/oncotarget.6791.

15.

Exosomes from human mesenchymal stem cells conduct aerobic metabolism in term and preterm newborn infants.

Panfoli I, Ravera S, Podestà M, Cossu C, Santucci L, Bartolucci M, Bruschi M, Calzia D, Sabatini F, Bruschettini M, Ramenghi LA, Romantsik O, Marimpietri D, Pistoia V, Ghiggeri G, Frassoni F, Candiano G.

FASEB J. 2016 Apr;30(4):1416-24. doi: 10.1096/fj.15-279679. Epub 2015 Dec 11.

PMID:
26655706
16.

Preterm Cord Blood Contains a Higher Proportion of Immature Hematopoietic Progenitors Compared to Term Samples.

Podestà M, Bruschettini M, Cossu C, Sabatini F, Dagnino M, Romantsik O, Spaggiari GM, Ramenghi LA, Frassoni F.

PLoS One. 2015 Sep 29;10(9):e0138680. doi: 10.1371/journal.pone.0138680. eCollection 2015.

17.

Detection of BCR-ABL T315I mutation by peptide nucleic acid directed PCR clamping and by peptide nucleic acid FISH.

Rosso V, Bracco E, Pedrola R, Carturan S, Signorino E, Petiti J, Calabrese C, Nicoli P, De Gobbi M, Gaidano V, Gallo D, Ulisciani S, Fava C, Rege-Cambrin G, Frassoni F, Saglio G, Cilloni D.

Biomark Res. 2015 Jul 3;3:15. doi: 10.1186/s40364-015-0039-y. eCollection 2015.

18.

Allogeneic cell transplant expands bone marrow distribution by colonizing previously abandoned areas: an FDG PET/CT analysis.

Fiz F, Marini C, Campi C, Massone AM, Podestà M, Bottoni G, Piva R, Bongioanni F, Bacigalupo A, Piana M, Sambuceti G, Frassoni F.

Blood. 2015 Jun 25;125(26):4095-102. doi: 10.1182/blood-2015-01-618215. Epub 2015 May 8.

19.

Impact of length of cryopreservation and origin of cord blood units on hematologic recovery following cord blood transplantation.

Kurita N, Frassoni F, Chiba S, Podestà M.

Bone Marrow Transplant. 2015 Jun;50(6):818-21. doi: 10.1038/bmt.2015.56. Epub 2015 Mar 23.

PMID:
25798681
20.

Improving the outcome of umbilical cord blood transplantation through ex vivo expansion or graft manipulation.

Horwitz ME, Frassoni F.

Cytotherapy. 2015 Jun;17(6):730-738. doi: 10.1016/j.jcyt.2015.02.004. Epub 2015 Mar 14. Review.

PMID:
25778757
21.

Mesenchymal stromal cells reset the scatter factor system and cytokine network in experimental kidney transplantation.

Gregorini M, Bosio F, Rocca C, Corradetti V, Valsania T, Pattonieri EF, Esposito P, Bedino G, Collesi C, Libetta C, Frassoni F, Dal Canton A, Rampino T.

BMC Immunol. 2014 Oct 3;15:44. doi: 10.1186/s12865-014-0044-1.

22.

Adult advanced chronic lymphocytic leukemia: computational analysis of whole-body CT documents a bone structure alteration.

Fiz F, Marini C, Piva R, Miglino M, Massollo M, Bongioanni F, Morbelli S, Bottoni G, Campi C, Bacigalupo A, Bruzzi P, Frassoni F, Piana M, Sambuceti G.

Radiology. 2014 Jun;271(3):805-13. doi: 10.1148/radiol.14131944. Epub 2014 Mar 5.

PMID:
24592961
23.

Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood.

Della Chiesa M, Falco M, Bertaina A, Muccio L, Alicata C, Frassoni F, Locatelli F, Moretta L, Moretta A.

J Immunol. 2014 Feb 15;192(4):1471-9. doi: 10.4049/jimmunol.1302053. Epub 2014 Jan 17.

24.

Foreword. New frontiers in molecular and cellular therapy.

Frassoni F, Locatelli F, Moretta L.

Immunol Lett. 2013 Sep-Oct;155(1-2):1. doi: 10.1016/j.imlet.2013.09.023. Epub 2013 Oct 8. No abstract available.

PMID:
24113356
25.

New possibilities to exploit the potentiality of cord blood cells in the context of transplantation.

Frassoni F, Cilloni D, Podestà M.

Immunol Lett. 2013 Sep-Oct;155(1-2):24-6. doi: 10.1016/j.imlet.2013.09.024. Epub 2013 Sep 27. Review. No abstract available.

PMID:
24080487
26.

Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease.

Ball LM, Bernardo ME, Roelofs H, van Tol MJ, Contoli B, Zwaginga JJ, Avanzini MA, Conforti A, Bertaina A, Giorgiani G, Jol-van der Zijde CM, Zecca M, Le Blanc K, Frassoni F, Egeler RM, Fibbe WE, Lankester AC, Locatelli F.

Br J Haematol. 2013 Nov;163(4):501-9. doi: 10.1111/bjh.12545. Epub 2013 Aug 31.

PMID:
23992039
27.

Design and application of a novel PNA probe for the detection at single cell level of JAK2V617F mutation in Myeloproliferative Neoplasms.

Bracco E, Rosso V, Serra A, Carnuccio F, Gaidano V, Nicoli P, Musto P, Saglio G, Frassoni F, Cilloni D.

BMC Cancer. 2013 Jul 18;13:348. doi: 10.1186/1471-2407-13-348.

28.

Trafficking and homing of systemically administered stem cells: the need for appropriate analysis tools of radionuclide images.

Sambuceti G, Massollo M, Marini C, Podestà M, Cassanelli C, Morbelli S, Fiz F, Buschiazzo A, Capitanio S, Augeri C, Curti G, Piana M, Frassoni F.

Q J Nucl Med Mol Imaging. 2013 Jun;57(2):207-15.

PMID:
23822992
29.

Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies.

Rocha V, Labopin M, Ruggeri A, Podestà M, Gallamini A, Bonifazi F, Sanchez-Guijo FM, Rovira M, Socie G, Baltadakis I, Michallet M, Deconinck E, Bacigalupo A, Mohty M, Gluckman E, Frassoni F.

Transplantation. 2013 May 27;95(10):1284-91. doi: 10.1097/TP.0b013e318288ca4d.

PMID:
23507699
30.

Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemia.

Cilloni D, Carturan S, Bracco E, Campia V, Rosso V, Torti D, Calabrese C, Gaidano V, Niparuck P, Favole A, Signorino E, Iacobucci I, Morano A, De Luca L, Musto P, Frassoni F, Saglio G.

Leuk Res. 2013 May;37(5):520-30. doi: 10.1016/j.leukres.2013.01.014. Epub 2013 Feb 12.

PMID:
23415111
31.

Differential effects of the type of iron chelator on the absolute number of hematopoietic peripheral progenitors in patients with β-thalassemia major.

Forni GL, Podestà M, Musso M, Piaggio G, Musallam KM, Balocco M, Pozzi S, Rosa A, Frassoni F.

Haematologica. 2013 Apr;98(4):555-9. doi: 10.3324/haematol.2012.076240. Epub 2012 Dec 14.

32.

Intrabone transplant of cord blood stem cells establishes a local engraftment store: a functional PET/FDG study.

Marini C, Podestà M, Massollo M, Capitanio S, Fiz F, Morbelli S, Brignone M, Bacigalupo A, Piana M, Frassoni F, Sambuceti G.

J Biomed Biotechnol. 2012;2012:767369. doi: 10.1155/2012/767369. Epub 2012 Oct 2.

33.

The impact of center experience on results of reduced intensity: allogeneic hematopoietic SCT for AML. An analysis from the Acute Leukemia Working Party of the EBMT.

Giebel S, Labopin M, Mohty M, Mufti GJ, Niederwieser D, Cornelissen JJ, Janssen JJ, Milpied N, Vindelov L, Petersen E, Arnold R, Bacigalupo A, Blaise D, Craddock C, Nagler A, Frassoni F, Sadus-Wojciechowska M, Rocha V.

Bone Marrow Transplant. 2013 Feb;48(2):238-42. doi: 10.1038/bmt.2012.131. Epub 2012 Jul 9.

PMID:
22773125
34.

Estimating the whole bone-marrow asset in humans by a computational approach to integrated PET/CT imaging.

Sambuceti G, Brignone M, Marini C, Massollo M, Fiz F, Morbelli S, Buschiazzo A, Campi C, Piva R, Massone AM, Piana M, Frassoni F.

Eur J Nucl Med Mol Imaging. 2012 Aug;39(8):1326-38. doi: 10.1007/s00259-012-2141-9. Epub 2012 May 26.

PMID:
22639281
35.

Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?

Della Chiesa M, Falco M, Podestà M, Locatelli F, Moretta L, Frassoni F, Moretta A.

Blood. 2012 Jan 12;119(2):399-410. doi: 10.1182/blood-2011-08-372003. Epub 2011 Nov 17.

36.

Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells.

Chiesa S, Morbelli S, Morando S, Massollo M, Marini C, Bertoni A, Frassoni F, Bartolomé ST, Sambuceti G, Traggiai E, Uccelli A.

Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17384-9. doi: 10.1073/pnas.1103650108. Epub 2011 Sep 29.

37.

CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus.

Mikulska M, Raiola AM, Bruzzi P, Varaldo R, Annunziata S, Lamparelli T, Frassoni F, Tedone E, Galano B, Bacigalupo A, Viscoli C.

Biol Blood Marrow Transplant. 2012 Jan;18(1):92-9. doi: 10.1016/j.bbmt.2011.05.015. Epub 2011 May 27.

38.

[Mesenchymal stromal cells injection reduces acute rejection damage in a rat experimental model of kidney transplantation].

Rampino T, Gregorini M, Bosio F, Bedino G, Corradetti V, Rocca C, Valsania T, Pattonieri EF, Piotti G, Soccio G, Zonta S, De Martino M, Dionigi P, Frassoni F, Dal Canton A.

G Ital Nefrol. 2011 Mar-Apr;28(2):132-4. Italian. No abstract available.

PMID:
21488020
39.

In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCT.

Dominietto A, Tedone E, Soracco M, Bruno B, Raiola AM, Van Lint MT, Geroldi S, Lamparelli T, Galano B, Gualandi F, Frassoni F, Bacigalupo A.

Bone Marrow Transplant. 2012 Jan;47(1):101-6. doi: 10.1038/bmt.2011.28. Epub 2011 Apr 4.

PMID:
21460867
40.

Helical tomotherapy targeting total bone marrow after total body irradiation for patients with relapsed acute leukemia undergoing an allogeneic stem cell transplant.

Corvò R, Zeverino M, Vagge S, Agostinelli S, Barra S, Taccini G, Van Lint MT, Frassoni F, Bacigalupo A.

Radiother Oncol. 2011 Mar;98(3):382-6. doi: 10.1016/j.radonc.2011.01.016. Epub 2011 Feb 19.

PMID:
21339008
41.

p38 MAPK and JNK antagonistically control senescence and cytoplasmic p16INK4A expression in doxorubicin-treated endothelial progenitor cells.

Spallarossa P, Altieri P, Barisione C, Passalacqua M, Aloi C, Fugazza G, Frassoni F, Podestà M, Canepa M, Ghigliotti G, Brunelli C.

PLoS One. 2010 Dec 20;5(12):e15583. doi: 10.1371/journal.pone.0015583.

42.

High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosis.

Rosti V, Bonetti E, Bergamaschi G, Campanelli R, Guglielmelli P, Maestri M, Magrini U, Massa M, Tinelli C, Viarengo G, Villani L, Primignani M, Vannucchi AM, Frassoni F, Barosi G; AGIMM Investigators.

PLoS One. 2010 Dec 9;5(12):e15277. doi: 10.1371/journal.pone.0015277.

43.

Rituximab treatment for Epstein-Barr virus DNAemia after alternative-donor hematopoietic stem cell transplantation.

Coppoletta S, Tedone E, Galano B, Soracco M, Raiola AM, Lamparelli T, Gualandi F, Bregante S, Ibatici A, di Grazia C, Dominietto A, Varaldo R, Bruno B, Frassoni F, Van Lint MT, Bacigalupo A.

Biol Blood Marrow Transplant. 2011 Jun;17(6):901-7. doi: 10.1016/j.bbmt.2010.10.003. Epub 2010 Oct 13.

44.

The intra-bone marrow injection of cord blood cells extends the possibility of transplantation to the majority of patients with malignant hematopoietic diseases.

Frassoni F, Varaldo R, Gualandi F, Bacigalupo A, Sambuceti G, Sacchi N, Podestà M.

Best Pract Res Clin Haematol. 2010 Jun;23(2):237-44. doi: 10.1016/j.beha.2010.06.003. Review.

PMID:
20837336
45.

Emerging targets for hematological malignancies.

Cilloni D, Frassoni F, Saglio G.

Curr Opin Drug Discov Devel. 2010 Sep;13(5):548-58. Review.

PMID:
20812146
46.

Mesenchymal stromal cells improve renal injury in anti-Thy 1 nephritis by modulating inflammatory cytokines and scatter factors.

Rampino T, Gregorini M, Bedino G, Piotti G, Gabanti E, Ibatici A, Sessarego N, Piacenza C, Balenzano CT, Esposito P, Bosio F, Soccio G, Frassoni F, Dal Canton A.

Clin Sci (Lond). 2011 Jan;120(1):25-36. doi: 10.1042/CS20100147.

PMID:
20583996
47.

Contact with the bone marrow microenvironment readdresses the fate of transplanted hematopoietic stem cells.

Massollo M, Podestà M, Marini C, Morbelli S, Cassanelli C, Pinto V, Ubezio G, Curti G, Uccelli A, Frassoni F, Sambuceti G.

Exp Hematol. 2010 Oct;38(10):968-77. doi: 10.1016/j.exphem.2010.06.003. Epub 2010 Jun 13.

PMID:
20550953
48.

Which is the most suitable and effective route of administration for mesenchymal stem cell-based immunomodulation therapy in experimental kidney transplantation: endovenous or arterial?

Zonta S, De Martino M, Bedino G, Piotti G, Rampino T, Gregorini M, Frassoni F, Dal Canton A, Dionigi P, Alessiani M.

Transplant Proc. 2010 May;42(4):1336-40. doi: 10.1016/j.transproceed.2010.03.081.

PMID:
20534295
49.

Mesenchymal stem cells infusion prevents acute cellular rejection in rat kidney transplantation.

De Martino M, Zonta S, Rampino T, Gregorini M, Frassoni F, Piotti G, Bedino G, Cobianchi L, Dal Canton A, Dionigi P, Alessiani M.

Transplant Proc. 2010 May;42(4):1331-5. doi: 10.1016/j.transproceed.2010.03.079.

PMID:
20534294
50.

Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemia.

Giebel S, Labopin M, Ehninger G, Beelen D, Blaise D, Ganser A, Bacigalupo A, Czerw T, Holowiecki J, Fagundes EM, Nowara E, Frassoni F, Rocha V; Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

Blood. 2010 Jul 8;116(1):122-8. doi: 10.1182/blood-2010-01-266478. Epub 2010 Apr 15.

Supplemental Content

Loading ...
Support Center